Using polyclonal and monoclonal antibodies in regulatory testing of biological products

ILAR Journal

Volumn 46, Issue 3, 2005, Pages 300-306

  Coe Clough, Nancy E ^a   Hauer, Paul J ^a  

^a UNITED STATES DEPARTMENT OF AGRICULTURE   (United States)

Author keywords

Assay design; Biologicals; Monoclonal antibody; Polyclonal antibody; Vaccine potency; Vaccine regulation

Indexed keywords

BIOLOGICAL PRODUCT; CLOSTRIDIUM TOXIN; ESCHERICHIA COLI VACCINE; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; TETANUS ANTIBODY; VACCINE;

ANIMAL HEALTH; ANTIBODY AFFINITY; ANTIBODY SPECIFICITY; ARTICLE; BACTERIAL INFECTION; DRUG EFFICACY; DRUG POTENCY; DRUG SCREENING; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNE RESPONSE; IMMUNOASSAY; IN VITRO STUDY; LABORATORY TEST; NONHUMAN; PATENT; PREDICTION; QUANTITATIVE ANALYSIS; STANDARDIZATION; VACCINATION; VALIDATION PROCESS; WORLD HEALTH ORGANIZATION;

ANIMALIA; CLOSTRIDIUM; ESCHERICHIA COLI;

EID: 21044431935     PISSN: 10842020     EISSN: None     Source Type: Journal    
DOI: 10.1093/ilar.46.3.300     Document Type: Article

References (10)

1. Anonymous. 2004. Clostridium Sordellii Bacterin-Toxoid. Part 113.109. In: Code of Federal Regulations, 2004. Title 9. Animals and Animal Products. Washington DC: GPO. p 635-637.
2. Batty I. 1971. Toxin-antitoxin assay. In: Norris JR, Ribbons, DW, eds. Methods in Microbiology. New York: Academic Press. p 255-279.
3. Crawley P. 1995. Antibody patents. In: Birch JR, Lennox ES, eds. Monoclonal Antibodies: Principles and Applications. New York: Wiley-Liss, Inc. p 299-335.
4. Harlow E, Lane D. 1999. Using Antibodies: A Laboratory Manual. Cold Spring Harbor: Cold Spring Harbor Laboratory Press.
5. Hauer PJ. 1997. Viewpoint from the USA authorities: Recent developments on different clostridiae. Pharmeuropa 97:47-57.
6. Hauer PJ, Clough NE. 1999. Development of monoclonal antibodies suitable for use in antigen quantification potency tests for clostridial veterinary vaccines. Dev Biol Stand 101:85-94.
7. Hauer PJ, Yeary TJ, Rosenbusch, RF. 2004. Cloning and molecular characterization of the beta toxin (phospholipase C) gene of Clostridium hemolyticum. Anaerobe 10:243-254.
8. NIAID [National Institute of Allergy and Infectious Diseases]. 2003. Summary of the NIAID Expert Panel on Botulism Diagnostics. Washington DC: GPO.
9. Roque ACA, Lowe CR, Taipa MA. 2004. Antibodies and genetically engineered related molecules: Production and purification. Biotechnol Prog 20:639-654.
10. Van Regenmortel HH. 2000. Binding measurements as surrogate biological assays: Surface plasmon resonance biosensors for characterizing vaccine components. Dev Biol Stand 103:69-74